287 related articles for article (PubMed ID: 32061928)
1. Homeobox D3, A Novel Link Between Bone Morphogenetic Protein 9 and Transforming Growth Factor Beta 1 Signaling.
Wang L; Yao J; Yu T; Zhang D; Qiao X; Yao Z; Wu X; Zhang L; Boström KI; Yao Y
J Mol Biol; 2020 Mar; 432(7):2030-2041. PubMed ID: 32061928
[TBL] [Abstract][Full Text] [Related]
2. Regulation of bone morphogenetic protein-4 by matrix GLA protein in vascular endothelial cells involves activin-like kinase receptor 1.
Yao Y; Zebboudj AF; Shao E; Perez M; Boström K
J Biol Chem; 2006 Nov; 281(45):33921-30. PubMed ID: 16950789
[TBL] [Abstract][Full Text] [Related]
3. Expression of vascular endothelial growth factor is coordinately regulated by the activin-like kinase receptors 1 and 5 in endothelial cells.
Shao ES; Lin L; Yao Y; Boström KI
Blood; 2009 Sep; 114(10):2197-206. PubMed ID: 19506300
[TBL] [Abstract][Full Text] [Related]
4. Serum/glucocorticoid-regulated kinase 1 as a novel transcriptional target of bone morphogenetic protein-ALK1 receptor signaling in vascular endothelial cells.
Araki M; Hisamitsu T; Kinugasa-Katayama Y; Tanaka T; Harada Y; Nakao S; Hanada S; Ishii S; Fujita M; Kawamura T; Saito Y; Nishiyama K; Watanabe Y; Nakagawa O
Angiogenesis; 2018 May; 21(2):415-423. PubMed ID: 29478089
[TBL] [Abstract][Full Text] [Related]
5. Bone morphogenetic protein (BMP) and activin type II receptors balance BMP9 signals mediated by activin receptor-like kinase-1 in human pulmonary artery endothelial cells.
Upton PD; Davies RJ; Trembath RC; Morrell NW
J Biol Chem; 2009 Jun; 284(23):15794-804. PubMed ID: 19366699
[TBL] [Abstract][Full Text] [Related]
6. A Bone Morphogenetic Protein (BMP)-derived Peptide Based on the Type I Receptor-binding Site Modifies Cell-type Dependent BMP Signalling.
Tong Z; Guo J; Glen RC; Morrell NW; Li W
Sci Rep; 2019 Sep; 9(1):13446. PubMed ID: 31530856
[TBL] [Abstract][Full Text] [Related]
7. DLL4/Notch1 and BMP9 Interdependent Signaling Induces Human Endothelial Cell Quiescence via P27KIP1 and Thrombospondin-1.
Rostama B; Turner JE; Seavey GT; Norton CR; Gridley T; Vary CP; Liaw L
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2626-37. PubMed ID: 26471266
[TBL] [Abstract][Full Text] [Related]
8. Bone morphogenetic protein 9 (BMP9) and BMP10 enhance tumor necrosis factor-α-induced monocyte recruitment to the vascular endothelium mainly via activin receptor-like kinase 2.
Mitrofan CG; Appleby SL; Nash GB; Mallat Z; Chilvers ER; Upton PD; Morrell NW
J Biol Chem; 2017 Aug; 292(33):13714-13726. PubMed ID: 28646109
[TBL] [Abstract][Full Text] [Related]
9. BMP9 (Bone Morphogenetic Protein-9)/Alk1 (Activin-Like Kinase Receptor Type I) Signaling Prevents Hyperglycemia-Induced Vascular Permeability.
Akla N; Viallard C; Popovic N; Lora Gil C; Sapieha P; Larrivée B
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1821-1836. PubMed ID: 29880487
[TBL] [Abstract][Full Text] [Related]
10. Bone morphogenetic proteins.
Chen D; Zhao M; Mundy GR
Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
[TBL] [Abstract][Full Text] [Related]
11. BMP9 induces EphrinB2 expression in endothelial cells through an Alk1-BMPRII/ActRII-ID1/ID3-dependent pathway: implications for hereditary hemorrhagic telangiectasia type II.
Kim JH; Peacock MR; George SC; Hughes CC
Angiogenesis; 2012 Sep; 15(3):497-509. PubMed ID: 22622516
[TBL] [Abstract][Full Text] [Related]
12. Anti-human activin receptor-like kinase 1 (ALK1) antibody attenuates bone morphogenetic protein 9 (BMP9)-induced ALK1 signaling and interferes with endothelial cell sprouting.
van Meeteren LA; Thorikay M; Bergqvist S; Pardali E; Stampino CG; Hu-Lowe D; Goumans MJ; ten Dijke P
J Biol Chem; 2012 May; 287(22):18551-61. PubMed ID: 22493445
[TBL] [Abstract][Full Text] [Related]
13. Crossveinless 2 regulates bone morphogenetic protein 9 in human and mouse vascular endothelium.
Yao Y; Jumabay M; Ly A; Radparvar M; Wang AH; Abdmaulen R; Boström KI
Blood; 2012 May; 119(21):5037-47. PubMed ID: 22474252
[TBL] [Abstract][Full Text] [Related]
14. Bone morphogenetic protein-9 inhibits lymphatic vessel formation via activin receptor-like kinase 1 during development and cancer progression.
Yoshimatsu Y; Lee YG; Akatsu Y; Taguchi L; Suzuki HI; Cunha SI; Maruyama K; Suzuki Y; Yamazaki T; Katsura A; Oh SP; Zimmers TA; Lee SJ; Pietras K; Koh GY; Miyazono K; Watabe T
Proc Natl Acad Sci U S A; 2013 Nov; 110(47):18940-5. PubMed ID: 24133138
[TBL] [Abstract][Full Text] [Related]
15. ALK1 Loss Results in Vascular Hyperplasia in Mice and Humans Through PI3K Activation.
Alsina-Sanchís E; García-Ibáñez Y; Figueiredo AM; Riera-Domingo C; Figueras A; Matias-Guiu X; Casanovas O; Botella LM; Pujana MA; Riera-Mestre A; Graupera M; Viñals F
Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1216-1229. PubMed ID: 29449337
[TBL] [Abstract][Full Text] [Related]
16. Endoglin differentially modulates antagonistic transforming growth factor-beta1 and BMP-7 signaling.
Scherner O; Meurer SK; Tihaa L; Gressner AM; Weiskirchen R
J Biol Chem; 2007 May; 282(19):13934-43. PubMed ID: 17376778
[TBL] [Abstract][Full Text] [Related]
17. BMP9 and BMP10 are critical for postnatal retinal vascular remodeling.
Ricard N; Ciais D; Levet S; Subileau M; Mallet C; Zimmers TA; Lee SJ; Bidart M; Feige JJ; Bailly S
Blood; 2012 Jun; 119(25):6162-71. PubMed ID: 22566602
[TBL] [Abstract][Full Text] [Related]
18. The TGFβ type I receptor TGFβRI functions as an inhibitor of BMP signaling in cartilage.
Wang W; Chun H; Baek J; Sadik JE; Shirazyan A; Razavi P; Lopez N; Lyons KM
Proc Natl Acad Sci U S A; 2019 Jul; 116(31):15570-15579. PubMed ID: 31311865
[TBL] [Abstract][Full Text] [Related]
19. A small molecule targeting ALK1 prevents Notch cooperativity and inhibits functional angiogenesis.
Kerr G; Sheldon H; Chaikuad A; Alfano I; von Delft F; Bullock AN; Harris AL
Angiogenesis; 2015 Apr; 18(2):209-17. PubMed ID: 25557927
[TBL] [Abstract][Full Text] [Related]
20. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling.
Goumans MJ; Valdimarsdottir G; Itoh S; Lebrin F; Larsson J; Mummery C; Karlsson S; ten Dijke P
Mol Cell; 2003 Oct; 12(4):817-28. PubMed ID: 14580334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
